Ads
related to: doxofylline for asthma guidelines- Patient Types
Identify The Appropriate Patient.
View Patient Types Today!
- Treatment Information
Discover Educational Resources
& Get Financial Support Information
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Resources
Coverage Information For Patients
Download Resources Today
- Patient Types
doconsumer.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma [1] and COPD. [2] Like theophylline, it is a xanthine derivative. [3] [4]
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
ATC code R03 Drugs for obstructive airway diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
Vivian Health examines five trends that could redefine nurses' roles, enhance patient care, and alter the entire healthcare system in 2025 and beyond.
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.
Ads
related to: doxofylline for asthma guidelinesdoconsumer.com has been visited by 100K+ users in the past month